News
In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.
Omicron variant may have picked up a piece of common-cold virus
By Nancy Lapid NEW YORK (Reuters) - The Omicron variant of the virus that causes COVID-19 likely acquired at least one of its mutations by picking up a snippet of genetic material from another virus -
Pre-eclampsia/eclampsia tied to increased risk of heart failure for at least 10 years
By Marilynn Larkin NEW YORK (Reuters Health) - Women with pre-eclampsia/eclampsia were at increased risk for future heart failure (HF) for up to a decade in a large cohort study. "While preeclampsia
Fat cell alterations implicated in breast cancer metastases
By Marilynn Larkin NEW YORK (Reuters Health) - In preclinical experiments, researchers have uncovered a mechanism linking fat cells altered by type 2 diabetes or insulin resistance to breast cancer
At least one year on bisphosphonates needed for fracture prevention
By Lisa Rapaport (Reuters Health) - It takes 12.4 months of bisphosphonate therapy to prevent one nonvertebral fracture per 100 postmenopausal women with osteoporosis, a meta-analysis of randomized
REUTERS NEXT-Researcher questions China's population data, says it may be lower
By Jane Lanhee Lee (Reuters) - China may be downplaying how fast its population is shrinking, and a recent policy to promote three-child families has poor chances to improve birth rates, a fertility
FDA clears use of Lilly's COVID-19 antibody therapy for kids
By Reuters Staff (Reuters) - The U.S. Food and Drug Administration on Friday authorized the use of Eli Lilly's COVID-19 dual-antibody therapy in treating mild to moderate symptoms in all children,
EXPLAINER-Could the Omicron variant bring milder illness?
By Deena Beasley (Reuters) - The Omicron variant, spreading now in southern Africa and detected in over 30 other countries, has prompted fears it could significantly undermine the effectiveness of
Omicron outbreak at Norway Christmas party is biggest outside S. Africa -authorities
By Gwladys Fouche and Nerijus Adomaitis OSLO (Reuters) - At least 13 people in Oslo have been infected with the Omicron variant of the coronavirus following a corporate Christmas party described as a
Valneva says no conclusions should be drawn on its vaccine from UK booster study
By Reuters Staff PARIS (Reuters) - French biotech firm Valneva said on Friday no conclusions should be drawn on the effectiveness of its COVID-19 vaccine by a British study, which found it was the
Artificial heart maker Carmat suspends implants due to quality issue
By Reuters Staff (Reuters) - French medical device company Carmat on Friday said it had suspended implants of its Aeson artificial hearts following a quality issue affecting some of its prostheses. "
Researchers find 'promising' blood biomarkers for cognitive decline in dementia
By Lorraine L. Janeczko NEW YORK (Reuters Health) - In dementia with Lewy bodies (DLB), plasma levels of phosphorylated-tau - p-tau181 and p-tau231 - may be accessible, cost-effective biomarkers for
Roche develops new research test kits for Omicron variant
By Brenna Hughes Neghaiwi ZURICH (Reuters) - Roche's newly acquired subsidiary TIB Molbiol has developed three new test kits to help researchers detect mutations in the new Omicron variant of
Bayer's Nubeqa drug improves survival in prostate cancer trial
By Ludwig Burger FRANKFURT (Reuters) - Bayer said a combination therapy including its Nubeqa drug was shown to prolong the lives of men suffering from metastatic prostate cancer in a clinical study,
IDSA advises eye protection as part of health worker PPE for suspected or known COVID patients
By Reuters Staff NEW YORK (Reuters Health) - In updated guidance, the Infectious Disease Society of America (IDSA) suggests that healthcare personnel caring for patients with suspected or known COVID-
Few doctor's offices provide accommodations for patients with significant vision impairment
By Linda Carroll NEW YORK (Reuters Health) - Just 10% of doctor's offices in the U.S. provide two basic accommodations - describing the clinic space and offering materials in large font - for patients
Lowering of CRC-screening age likely to affect colonoscopy demand, case mix, adenoma detection
By Reuters Staff NEW YORK (Reuters Health) - The recent lowering of colorectal cancer (CRC)-screening age from 50 to 45 years is likely to affect demand for colonoscopy and case mix, and result in a
Genetic subtype of lymphoma determines ibrutinib response
By Matthew Phelan NEW YORK (Reuters Health) - Younger patients with two genetic subtypes of diffuse large B-cell lymphoma (DLBCL) - MCD and N1 - had a three-year survival of 100% in the phase-3
Experimental malaria vaccine continues to show promise
By Reuters Staff NEW YORK (Reuters Health) - A study conducted in West Africa confirms the protective efficacy of an experimental malaria vaccine against naturally occurring infection and shows it can
Italian anti-vaxxer tries to get COVID-19 jab in fake arm
By Reuters Staff ROME (Reuters) - An Italian man turned up at a vaccination centre wearing a fake silicone arm, hoping to fool a nurse into giving him a jab in order to obtain a COVID-19 health
England's COVID-19 prevalence rises, led by Delta not Omicron
By Reuters Staff LONDON (Reuters) - The prevalence of COVID-19 infections in England rose to around 1 in 60 people in the week ending Nov. 27, Britain's Office for National Statistics said on Friday,
Geneva places 2,000 people in quarantine after two Omicron cases
By Brenna Hughes Neghaiwi ZURICH (Reuters) - The Swiss cantons of Geneva and Vaud have placed 2,000 people, most of them children, into quarantine after two cases of the Omicron variant were detected
REUTERS NEXT-WHO chief scientist says Omicron 'quite infectious', must not panic
By Francesco Guarascio and Stephanie Nebehay (Reuters) - The World Health Organization's chief scientist Soumya Swaminathan told the Reuters Next conference on Friday that while the new coronavirus
UK study finds mRNA COVID-19 vaccines provide biggest booster impact
By Alistair Smout LONDON (Reuters) - COVID-19 vaccines made by Pfizer and Moderna that use mRNA technology provide the biggest boost to antibody levels when given 10-12 weeks after the second dose, a
Verubecestat promising for glioblastoma
By Marilynn Larkin NEW YORK (Reuters Health) - Verubecestat, a beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1) inhibitor originally developed to treat Alzheimer's disease, showed promise
Extracoronary vascular events likely rare after spontaneous coronary artery dissection
By Marilynn Larkin NEW YORK (Reuters Health) - In patients with spontaneous coronary artery dissection (SCAD), severe vascular events were rare in a case series with five-year follow-up. "SCAD is a
Enriched infant formula does not improve later academic performance
By Lisa Rapaport (Reuters Health) - Giving infants nutritionally enriched baby formula won't lead to better grades in English or math during adolescence, a recent study suggests. Researchers examined
Omicron COVID-19 variant found in three U.S. states
By Kanishka Singh and Susan Heavey (Reuters) - Three U.S. states have found cases of the Omicron coronavirus variant -- California, Colorado and Minnesota -- among patients who were fully vaccinated
ANALYSIS-Trump's U.S. Supreme Court appointees poised to deliver on abortion
By Andrew Chung and Lawrence Hurley WASHINGTON (Reuters) - The month before being elected president in 2016, Donald Trump promised during a debate with his opponent Hillary Clinton to name justices to
S.Africa's health body sees threefold higher risk of reinfection from Omicron
By Reuters Staff JOHANNESBURG (Reuters) - The new Omicron variant of the coronavirus poses a threefold higher risk of reinfection than the currently dominant Delta variant and the Beta strain, a group
EU regulator begins real-time review of Valneva's COVID-19 shot
By Reuters Staff (Reuters) - The European Union's drug regulator said on Thursday it had started a rolling review of the inactivated-virus COVID-19 vaccine from French biotech firm Valneva, weeks
UPDATE 1-Israel halts disputed Omicron tracing through phone surveillance
(Recasts for halt to practice, updates case figures) By Reuters Staff JERUSALEM (Reuters) - Israel said on Thursday it was halting the use of mobile phone tracing to curb the spread of the new
FACTBOX-U.S. Omicron plan: boosters, free at-home tests, tighter travel rules
By Reuters Staff WASHINGTON (Reuters) - The Biden administration is seeking to ramp up its pandemic response amid the official arrival of the Omicron coronavirus variant, laying out a plan on Thursday
UPDATE 1-Omicron may become dominant in Europe in months -EU
(Adds details throughout) By Reuters Staff BRUSSELS (Reuters) - The European Union's public health agency said on Thursday that the Omicron variant could be responsible for more than half of all COVID
Psoriasis tied to small increase in risk of venous thromboembolism, peripheral vascular disease
By Linda Carroll NEW YORK (Reuters Health) - Venous thromboembolism (VTE) and peripheral vascular disease (PVD) may be slightly more likely to develop among patients with psoriasis than those without
Second U.S. Omicron variant case identified in Minnesota
By Reuters Staff (Reuters) - A case of the Omicron coronavirus variant was identified in Minnesota on Thursday, the U.S. state's health department said, with the identification coming a day after the
'Milestone' in stem-cell-based islet replacement for type-1 diabetes
By Reuters Staff NEW YORK (Reuters Health) - Interim results from an ongoing multicenter clinical trial show that implanted pluripotent-stem-cell-derived endocrine progenitor cells can secrete insulin
SPECIAL REPORT-U.S. rushed contracts to COVID-19 suppliers with troubled plants
By Marisa Taylor WASHINGTON (Reuters) - As the Trump administration debated whether to declare COVID-19 a national emergency early last year, a little-known U.S. health office issued a public plea to
Israel's top court rejects petition against Omicron phone tracking
By Reuters Staff JERUSALEM (Reuters) - Israel's Supreme Court on Thursday rejected a petition by rights groups seeking to repeal temporary measures allowing the domestic intelligence agency to use
Third mRNA vaccine dose boosts immunity against SARS-CoV-2 variants in transplant recipients
By Lorraine L. Janezko NEW YORK (Reuters Health) - In organ transplant recipients, a third dose of the Moderna COVID-19 vaccine appears to increase neutralizing antibody response against SARS-CoV-2
Moderate COVID-19 infection in pregnancy unlikely to harm the fetal brain
By Megan Brooks NEW YORK (Reuters Health) - Mild to moderate COVID-19 infection during pregnancy appears to have no harmful effect on the brain of the developing fetus, according to a small study. "
Prenatal alcohol exposure alters fetal brain structure
By Megan Brooks NEW YORK (Reuters Health) - Radiologists observed significant changes in the brain structure of fetuses exposed to alcohol in the first MRI-based study to investigate the issue. "We
Finland to limit children's COVID-19 vaccines to high-risk households
By Essi Lehto HELSINKI (Reuters) - Children in Finland aged five and over should be vaccinated against COVID-19 if they or someone in their household are at high risk of severe infection, the Finnish
New Delhi shuts schools, colleges again due to air pollution
By Reuters Staff NEW DELHI (Reuters) - India's capital New Delhi has ordered the closure of schools and colleges until further notice from Friday after the Supreme Court criticised the city government
Omicron may soon cause over half of COVID infections in Europe -EU
By Reuters Staff BRUSSELS (Reuters) - The European Union's public health agency said on Thursday that the Omicron variant could be responsible for more than half of all COVID-19 infections in Europe
GSK says tests indicate antibody drug works against Omicron
By Ludwig Burger (Reuters) - Laboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (GSK) is developing with U.S. partner Vir has indicated the drug is effective against the new
S.Africa sees rise in COVID reinfections from Omicron, mild symptoms - scientist
By Katharine Houreld and Ayenat Mersie NAIROBI (Reuters) - South Africa is seeing an increase in COVID-19 reinfections due to the Omicron variant but symptoms for reinfected patients and those
Structured exercise aids arm function after breast cancer surgery
By Lisa Rapaport (Reuters Health) - Women who have non-reconstructive breast cancer surgery may experience better arm function when they follow a structured exercise program in addition to usual care,
Cytoreductive surgery beneficial when ovarian cancer recurs
By Reuters Staff NEW YORK (Reuters Health) - Adding cytoreductive surgery to chemotherapy can help women with recurrent ovarian cancer live nearly eight months longer than chemotherapy alone,
Biden seeks end to AIDS epidemic in the United States by 2030
By Jarrett Renshaw and Nandita Bose (Reuters) - U.S. President Joe Biden on Wednesday unveiled an updated national strategy to combat the AIDS epidemic with a goal of ending it by 2030. "We are within
Antihistamines linked to better immunotherapy response in cancer patients
By Marilynn Larkin NEW YORK (Reuters Health) - In cancer patients receiving immunotherapy, antihistamine drugs may improve outcomes, retrospective and preclinical analyses suggest. "We know some
Rituximab likely raises risk of hospital death in COVID-19 patients
By Marilynn Larkin NEW YORK (Reuters Health) - In hospitalized COVID-19 patients on immunosuppressive therapy, only those taking rituximab had an increased risk of in-hospital death in a retrospective
First known U.S. Omicron case found in fully vaccinated overseas traveler
By Trevor Hunnicutt WASHINGTON (Reuters) - The United States on Wednesday identified its first known case of Omicron, discovered in a fully vaccinated patient who traveled to South Africa, as
Moderna exec says company could have Omicron booster ready in March
By Michael Erman and Julie Steenhuysen NEW YORK (Reuters) - Moderna Inc could have a COVID-19 booster shot targeting the Omicron variant tested and ready to file for U.S. authorization as soon as
EXPLAINER-Does Omicron pose higher risks for infants than other variants?
By Alexander Winning and Tim Cocks JOHANNESBURG (Reuters) - Data from an area in South Africa hard-hit by the Omicron variant of the coronavirus has shown a high number of hospital admissions of
S.African data suggests Omicron gets around some, not all immunity
By Promit Mukherjee and Estelle Shirbon JOHANNESBURG (Reuters) - The Omicron variant appears able to get around some immunity but vaccines should still offer protection against severe disease,
U.S. Supreme Court conservatives lean toward limiting abortion
By Lawrence Hurley and Andrew Chung WASHINGTON (Reuters) - Conservative U.S. Supreme Court justices on Wednesday signaled support for curbing abortion rights in America by upholding a restrictive
UPDATE 1-Botswana's health director says majority of Omicron variant cases were asymptomatic
(Adds details, quote) By Promit Mukherjee JOHANNESBURG (Reuters) - A senior Botswana health official said on Tuesday that 16 out of the total 19 cases of the Omicron coronavirus variant detected in
Vaccine coverage below 10% in seven eastern Mediterranean nations - WHO
By Reuters Staff CAIRO (Reuters) - An official at the WHO's Eastern Mediterranean Regional Office said on Wednesday seven countries in the region have not yet reached a threshold of 10% vaccination
Botswana's health director says majority of Omicron variant cases were asymptomatic
By Reuters Staff JOHANNESBURG (Reuters) - A top official in Botswana's health ministry said on Tuesday that 16 out of the total 19 cases of the Omicron variant detected in the country were
High early amino acid intake in preemies might have positive brain effects
By Megan Brooks NEW YORK (Reuters Health) - For babies born before 30 weeks' gestation, high early amino acid intake is safe and associated with improved cognitive development at 5 years of age,
Colchicine may not cut risk of death from COVID-19: meta-analysis
By Linda Carroll NEW YORK (Reuters Health) - The gout drug colchicine does not appear to lessen COVID-19 severity or stave off death from the disease, according to a new meta-analysis that contradicts
Viral RNA in blood an early predictor of COVID-19 death
By Megan Brooks NEW YORK (Reuters Health) - The amount of viral RNA in blood can reliably identity patients who are at higher risk of dying from COVID-19, a new study suggests. "There is no need to
Older blood thinners tied to increased risk of delayed brain bleeds after head injury
By Megan Brooks NEW YORK (Reuters Health) - Patients taking clopidogrel or warfarin have a significantly higher risk of suffering delayed brain bleeding and dying following head trauma than peers
Activists rally as U.S. Supreme Court hears high-stakes abortion case
By Gabriella Borter, Julia Harte and Jan Wolfe WASHINGTON (Reuters) - Carrying signs and playing music, hundreds of people favoring and opposing abortion rights staged dueling rallies in front of the
REUTERS NEXT-COVID-19 took toll on AIDS fight, UNAIDS chief says
By Julie Steenhuysen CHICAGO (Reuters) - New infections and deaths from HIV/AIDS may increase as the COVID-19 pandemic has disrupted prevention measures, said UNAIDS Executive Director Winnie Byanyima
WHO agrees to launch talks on pact to tackle pandemics
By Stephanie Nebehay GENEVA (Reuters) - The World Health Organization (WHO) agreed on Wednesday to launch negotiations on an international pact to prevent and control future pandemics at a time when
White House says DOJ will defend government's authority to promote vaccine requirement
By Nandita Bose WASHINGTON (Reuters) - The White House said on Wednesday the U.S. Department of Justice "will vigorously defend" the government's authority to promote its vaccine requirement in
EU brings forward Pfizer/BioNTech COVID shot for younger children to Dec 13
By Andreas Rinke and Ludwig Burger FRANKFURT (Reuters)- The European Union-wide rollout of Pfizer and BioNTech's COVID-19 vaccine version for five- to 11-year-old children will begin Dec 13, one week
Laparoscopic distal gastrectomy noninferior to open procedures for gastric cancer
By Lisa Rapaport (Reuters Health) - Patients with locally advanced gastric cancer have similar five-year overall survival outcomes with laparoscopic and open distal gastrectomy, a recent study
New York City opens first U.S. sites for supervised narcotics injection
By Maria Caspani NEW YORK (Reuters) - The first sites in the United States that allow narcotics users to inject drugs under the supervision of trained staff opened in New York City on Tuesday, a move
Fauci: Too soon to say if Omicron variant will lead to severe disease
By Jeff Mason and Ahmed Aboulenein (Reuters) - It is too early to know whether Omicron variant of COVID-19 will lead to severe disease, but preliminary information from South Africa indicates it does
Guselkumab boosts response in resistant psoriatic arthritis
By Marilynn Larkin NEW YORK (Reuters Health) - In patients with psoriatic arthritis (PsA) who are resistant to tumor necrosis factor inhibitors (TNFi), guselkumab was more effective than placebo in a
Hospitalization for COVID-19 during pregnancy tied to increased rate of complications
By Linda Carroll NEW YORK (Reuters Health) - Pregnant women who are hospitalized for COVID-19 are more likely to have complications during pregnancy and birth, compared to those who don't catch the
Overtreatment of early papillary thyroid neoplasms continues, despite preventive strategies
By Marilynn Larkin NEW YORK (Reuters Health) - Strategies to prevent overtreatment of papillary thyroid carcinomas (PTCs) have had mixed success, a cohort study shows. "Both of our major findings
No support for calcium administration during out-of-hospital cardiac arrest
By Reuters Staff NEW YORK (Reuters Health) - Treatment with intravenous or intraosseous calcium during out-of-hospital cardiac arrest does not improve the likelihood of sustained return of spontaneous
Atezolizumab, nivolumab tied to longer survival than docetaxel in advanced lung cancer
By Lorraine L. Janeczko NEW YORK (Reuters Health) - Patients with advanced non-small-cell lung cancer (NSCLC) who are treated with atezolizumab or nivolumab appear to survive longer than those treated
Value of fourth COVID-19 vaccine shot in patients with solid-organ transplants questionable
By Megan Brooks NEW YORK (Reuters Health) - Giving solid-organ-transplant recipients a fourth dose of mRNA COVID-19 vaccine may lead to only a slight improvement in SARS-CoV-2 antibody concentrations
Study reveals spectrum of COVID-19 brain complications
By Megan Brooks NEW YORK (Reuters Health) - Brain complications including stroke and hemorrhage occur in about one in 100 hospitalized patients with COVID-19, new research suggests. "There should
BioNTech CEO says vaccine likely to protect against severe COVID from Omicron
By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) - BioNTech and Pfizer's COVID-19 vaccine will likely offer strong protection against any severe disease from the new Omicron virus variant,
How South African scientists spotted the Omicron COVID variant
By Tim Cocks JOHANNESBURG (Reuters) - On Friday Nov. 19, Raquel Viana, Head of Science at one of South Africa's biggest private testing labs, sequenced the genes on eight coronavirus samples - and got
The race is on to trace the new COVID-19 variant
By Alistair Smout, Francesco Guarascio and Chen Lin LONDON/BRUSSELS/SINGAPORE (Reuters) - Governments around the world are urgently scouring databases for recent cases of COVID-19 infections,
Omicron variant could outcompete Delta, South African disease expert says
By Alexander Winning JOHANNESBURG (Reuters) - The Omicron coronavirus variant detected in southern Africa could be the most likely candidate to displace the highly contagious Delta variant, the
Hybrid closed-loop therapy boosts glycemic control in youth with type-1 diabetes
By Scott Baltic NEW YORK (Reuters Health) - In children and adolescents with type-1 diabetes, a hybrid closed-loop (HCL) system significantly improved glycemic control and quality of life compared
GSK names Pfizer scientist Dormitzer as vaccines R&D head
By Reuters Staff (Reuters) - GSK has hired one of the scientists behind Pfizer's mRNA COVID-19 shot, Phil Dormitzer, as its global head of R&D for vaccines and he will join the British drugmaker from
Mask mandates to tackle Omicron come into force in England
By Reuters Staff LONDON (Reuters) - New mask mandates and other measures aimed at curbing the spread of the Omicron coronavirus variant came into force in England on Tuesday, as Prime Minister Boris
WHO's Tedros warns against over-reaction to Omicron
By Stephanie Nebehay GENEVA (Reuters) - The head of the World Health Organization (WHO) voiced concern on Tuesday that some countries were introducing blanket measures against the Omicron coronavirus
Regeneron says its COVID-19 antibody drug could be less effective against Omicron
By Reuters Staff (Reuters) - Regeneron Pharmaceuticals Inc's COVID-19 antibody treatment and other similar drugs could be less effective against the new Omicron coronavirus variant, the company said
Mercury exposure from seafood consumption not tied to cardiovascular and all-cause mortality in US
By Linda Carroll (Reuters Health) - People can enjoy the health benefits of seafood consumption without worrying that the mercury in the food will shorten their lives, a new study suggests. An
Judge blocks U.S. COVID-19 vaccine rule for health workers in 10 states
By Tom Hals (Reuters) - A federal judge on Monday blocked in 10 states a Biden administration vaccine requirement, finding the agency that issued the rule mandating healthcare workers get vaccinated
ABMS member boards follow parental, caregiver and medical leave mandate
By Lisa Rapaport (Reuters Health) - Specialty training programs two years or longer all follow a new American Board of Medical Specialties (ABMS) mandate for six weeks of parental, caregiver, or
Telehealth exercise and diet programs curb pain and boost function in knee osteoarthritis
By Marilynn Larkin NEW YORK (Reuters Health) - In patients with knee osteoarthritis, telehealth-delivered exercise and diet programs are superior to electronic health information for reducing pain and
Certain gut microbiota more responsive to low FODMAP diet for IBS
By Marilynn Larkin NEW YORK (Reuters Health) - In patients with irritable bowel syndrome (IBS), those with certain gut microbiota species responded better to a low FODMAP diet, researchers suggest. A
